SFX by Ex Libris Inc.

Title:	BRCA1 mutations in primary breast and ovarian carcinomas
Source:	Science [0036-8075] Futreal, P A yr:1994

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Ding, C. "A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1." Science 266.5182: 66-71.
description	2.	Farmer, H. "Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy." Nature 434.7035 (2005): 917-21.
description	3.	Psych, M R C R. "The neurodevelopmental model of schizophrenia: update 2005." Molecular psychiatry 10.5: 434-449.
description	4.	Gonzalez, M. "Extremely high thermal stability of streptavidin and avidin upon biotin binding." Biomolecular engineering 16.1-4 (1999): 67-72.
description	5.	Hacia, J G G. "Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysis." Nature genetics 14.4 (1996): 441-447.
description	6.	Wooster, Richard, G. "Identification of the breast cancer susceptibility gene BRCA2." Nature 378.6559 (1995): 789-92.
description	7.	Wooster, R. "Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13." Science 265.5181: 2088-2090.
description	8.	Morrow, J E M. "Linkage of early-onset familial breast cancer to chromosome 17q21." Science 250.4988 (1991): 1684-9.
description	9.	Foulkes, William D D. "BRCA1 and BRCA2: 1994 and beyond." Nature reviews. Cancer 4.9 (2004): 665-76.
description	10.	Bryant, Helen E. "Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase." Nature 447.7142 (2007): 346-7.
description	11.	Brewer, Warrick J J. "Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis." Schizophrenia Bulletin 32.3 (2006): 538-55.
description	12.	Keller, Matthew C. "Endophenotypes in the genetic analyses of mental disorders." Annual review of clinical psychology 2.2006 (2006): 267290-90.
description	13.	Lewis, David A A. "Schizophrenia as a disorder of neurodevelopment." Annual review of neuroscience 25.1 (2002): 409-32.
description	14.	Boss, D. "Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers." New England Journal of Medicine, The 361.2 (2009): 123-134.
description	15.	Tutt, A. "Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial." The Lancet 376.9737 (2010): 235-244.
description	16.	Rapoport, Judith L L. "The neurodevelopmental model of schizophrenia: what can very early onset cases tell us?" Current psychiatry reports 7.2: 81-82.
description	17.	Tsuang, Tyrone D E. "Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions." Schizophrenia Bulletin 29.4 (2003): 653-69.
description	18.	Holmes, Michael C C. "Highly efficient endogenous human gene correction using designed zinc-finger nucleases." Nature 435.7042: 646-651.
description	19.	Kapranov, P. "Large-scale transcriptional activity in chromosomes 21 and 22." Science 296.5569 (2002): 916-919.
description	20.	Scully, R. "In search of the tumour-suppressor functions of BRCA1 and BRCA2." Nature 408.6811 (2000): 429-32.